• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Plasma kinetics of lipoprotein lipase and hepatic lipase activities induced by heparin and a low molecular weight heparin fragment.

作者信息

Persson E, Nordenström J, Nilsson-Ehle P

出版信息

Scand J Clin Lab Invest. 1987 Apr;47(2):151-5.

PMID:3576117
Abstract

Intravenous injections of conventional heparin and a low molecular weight heparin fragment (LMWH, mean molecular weight 4000-6000) were given to six male volunteers at doses of 10, 50 and 100 U (antiFXa)/kg body wt. The plasma kinetics of lipoprotein lipase (LPL) and hepatic lipase (HL) were analysed. The peak values, as well as the accumulated release of LPL activity, were dose dependent and were twice as high after heparin as after LMWH. The plasma half-life of LPL activity followed first order kinetics and was similar for both heparin preparations when given in comparable doses. The peak values and the plasma half-life of HL activity were the same for heparin and LMWH in the clinically relevant doses (50 and 100 U (antiFXa)/kg). Compared with LMWH, the total release of HL was twice as large after the heparin injections, possibly due to mobilization of an additional enzyme pool by the conventional heparin. It is concluded that the use of LMWH as an anticoagulant is associated with a lower plasma lipolytic activity than with standard heparin.

摘要

相似文献

1
Plasma kinetics of lipoprotein lipase and hepatic lipase activities induced by heparin and a low molecular weight heparin fragment.
Scand J Clin Lab Invest. 1987 Apr;47(2):151-5.
2
Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).脂蛋白脂肪酶、肝脂肪酶与血浆脂解活性。肝素及低分子量肝素片段(法安明)的作用
Acta Med Scand Suppl. 1988;724:1-56.
3
Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme.与给予传统肝素后相比,输注低分子量肝素后脂蛋白脂肪酶的血浆水平较低,这表明该酶的分解代谢更快。
J Lab Clin Med. 2003 Aug;142(2):90-9. doi: 10.1016/S0022-2143(03)00059-3.
4
Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted.持续输注肝素期间的脂蛋白脂肪酶:组织储备会部分耗尽。
J Lab Clin Med. 2001 Sep;138(3):206-13. doi: 10.1067/mlc.2001.117666.
5
Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment.皮下注射肝素和低分子量肝素片段后的血浆脂解活性。
Thromb Res. 1987 Jun 1;46(5):697-704. doi: 10.1016/0049-3848(87)90271-4.
6
In vivo and in vitro release of lipoprotein lipase and hepatic lipase by low molecular weight heparins.低分子量肝素在体内和体外对脂蛋白脂肪酶和肝脂肪酶的释放作用。
Arch Int Pharmacodyn Ther. 1989 Jan-Feb;297:286-93.
7
Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.肝素治疗期间组织因子途径抑制物的血管内释放及尿排泄
J Lab Clin Med. 2004 Nov;144(5):246-53; discussion 226-7. doi: 10.1016/j.lab.2004.08.001.
8
A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment.一项比较普通肝素与低分子量肝素片段的人体药理学研究。
Thromb Haemost. 1985 Apr 22;53(2):208-11.
9
Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.在2型糖尿病患者和健康受试者中,肝素后血浆脂蛋白脂肪酶而非肝脂肪酶活性与血浆脂联素相关。
Clin Lab. 2005;51(7-8):403-9.
10
Pharmacokinetics of heparin and its pharmacodynamic effect on plasma lipoprotein lipase activity and coagulation in healthy horses.
Am J Vet Res. 1995 Aug;56(8):1070-4.

引用本文的文献

1
Lack of plasma albumin impairs intravascular lipolysis and explains the associated free fatty acids deficiency and hypertriglyceridemia.缺乏血浆白蛋白会损害血管内脂肪分解,并解释了相关的游离脂肪酸缺乏和高三酰甘油血症。
Lipids Health Dis. 2010 Dec 27;9:146. doi: 10.1186/1476-511X-9-146.
2
Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme.血液透析患者中的脂蛋白脂肪酶:尽管血浆中该酶水平较低,但有迹象表明低分子量肝素会消耗其功能储备。
BMC Nephrol. 2004 Nov 3;5:17. doi: 10.1186/1471-2369-5-17.
3
A method for producing regional hypoglycemia in blood perfused tissue.
Mol Cell Biochem. 1999 Oct;200(1-2):177-81. doi: 10.1023/a:1006980419023.
4
Nonesterified fatty acids in acute cerulein-induced pancreatitis in the rat. Are they really deleterious in vivo?大鼠急性蛙皮素诱导性胰腺炎中游离脂肪酸的研究。它们在体内真的有害吗?
Dig Dis Sci. 1995 Mar;40(3):540-5. doi: 10.1007/BF02064365.
5
Low-Mr heparin is as potent as conventional heparin in releasing lipoprotein lipase, but is less effective in preventing hepatic clearance of the enzyme.低分子量肝素在释放脂蛋白脂肪酶方面与传统肝素一样有效,但在防止该酶的肝脏清除方面效果较差。
Biochem J. 1991 Feb 1;273 ( Pt 3)(Pt 3):747-52. doi: 10.1042/bj2730747.
6
[Low molecular weight heparin: how does it modify lipid metabolism in chronic hemodialysis patients?].[低分子量肝素:它如何改变慢性血液透析患者的脂质代谢?]
Klin Wochenschr. 1991 Oct 18;69(16):749-56. doi: 10.1007/BF01797613.
7
Interaction of size-fractionated heparins with lipoprotein lipase and hepatic lipase in the rat.大鼠中不同大小片段肝素与脂蛋白脂肪酶和肝脂肪酶的相互作用。
Biochem J. 1992 Aug 1;285 ( Pt 3)(Pt 3):731-6. doi: 10.1042/bj2850731.